All Stories

  1. Direct and indirect modulation of STAT3/CSE/H2S axis in triple negative breast cancer by non-coding RNAs: MALAT-1 lncRNA, miR-486–5p and miR-30a-5p
  2. Emerging roles of hydrogen sulfide-metabolizing enzymes in cancer
  3. Nitro fatty acids: A comprehensive review on analytical methods and levels in health and disease
  4. Pan-inhibition of the three H2S synthesizing enzymes restrains tumor progression and immunosuppression in breast cancer
  5. Role of Hydrogen Sulfide in Oncological and Non-Oncological Disorders and Its Regulation by Non-Coding RNAs: A Comprehensive Review
  6. Antibacterial and in vitro anticancer activities of the antimicrobial peptide NRC‐07 encapsulated in chitosan nanoparticles
  7. Determination of Capecitabine and Its Metabolites in Plasma of Egyptian Colorectal Cancer Patients
  8. Dual targeting of H2S synthesizing enzymes; cystathionine β-synthase and cystathionine γ-lyase by miR-939-5p effectively curbs triple negative breast cancer
  9. Role of Cystathionine β-Synthase and 3-Mercaptopyruvate Sulfurtransferase in the Regulation of Proliferation, Migration, and Bioenergetics of Murine Breast Cancer Cells
  10. Development and Validation of a Bioanalytical Method for the Quantification of Nitrated Fatty Acids in Plasma Using LC-MS/MS: Application to Cardiovascular Patients
  11. Let-7a/cMyc/CCAT-1/miR-17-5p Circuit Modulates PDL-1 Expression and Atezolizumab Resistance in Triple Negative Breast Cancer
  12. High Glucose Increases DNA Damage and Elevates the Expression of Multiple DDR Genes
  13. Ozonated Olive Oil: Enhanced Cutaneous Delivery via Niosomal Nanovesicles for Melanoma Treatment
  14. Uncoupling tumor necrosis factor-α and interleukin-10 at tumor immune microenvironment of breast cancer through miR-17-5p/MALAT-1/H19 circuit
  15. What is beyond LncRNAs in breast cancer: A special focus on colon cancer-associated Transcript-1 (CCAT-1)
  16. miR-744/eNOS/NO axis: A novel target to halt triple negative breast cancer progression
  17. miRNA-506-3p Directly Regulates rs10754339 (A/G) in the Immune Checkpoint Protein B7-H4 in Breast Cancer
  18. Over a century since ephedrine discovery: an updated revisit to its pharmacological aspects, functionality and toxicity in comparison to its herbal extracts
  19. Point-of-care testing and optimization of sample treatment for fluorometric determination of hydrogen sulphide in plasma of cardiovascular patients
  20. LncRNA HEIH/miR‐939‐5p interplay modulates triple‐negative breast cancer progression through NOS2‐induced nitric oxide production
  21. Short Non-coding RNAs: Promising Biopharmaceutical Weapons in Breast Carcinogenesis
  22. MicroRNA-486-5p and microRNA-486-3p: Multifaceted pleiotropic mediators in oncological and non-oncological conditions
  23. The association of megalin and cubilin genetic variants with serum levels of 25-hydroxvitamin D and the incidence of acute coronary syndrome in Egyptians: A case control study
  24. An acetylated derivative of vitexin halts MDA-MB-231 cellular progression and improves its immunogenic profile through tuning miR- 20a-MICA/B axis
  25. Long non-coding RNAs: Functional regulatory players in breast cancer
  26. A methoxylated quercetin glycoside harnesses HCC tumor progression in a TP53/miR-15/miR-16 dependent manner
  27. A novel role of sONE/NOS3/NO signaling cascade in mediating hydrogen sulphide bilateral effects on triple negative breast cancer progression
  28. C(-260)T Polymorphism in CD14 Receptor Gene of Egyptians with Acute Myocardial Infarction
  29. Genetic Variants of CYP2R1 Are Key Regulators of Serum Vitamin D Levels and Incidence of Myocardial Infarction in Middle-Aged Egyptians
  30. Association of Thrombospondin-1 (N700S) and Thrombospond in-4 (A387P) Gene Polymorphisms with the Incidence of Acute Myocardial Infarction in Egyptians
  31. Polymorphisms in Gap Junction Proteins and their Role in Predisposition of Acute Myocardial Infarction in Egyptians
  32. Addressing the link between paraoxonase-1 gene variants and the incidence of early onset myocardial infarction
  33. Overexpression of NMDAR2B in an inflammatory model of Alzheimer's disease: Modulation by NOS inhibitors
  34. Triangular relationship between single nucleotide polymorphisms in the CYP2R1 gene (rs10741657 and rs12794714), 25-hydroxyvitamin d levels, and coronary artery disease incidence
  35. Design-of-Experiment Approach for HPLC Analysis of 25-Hydroxyvitamin D: A Comparative Assay with ELISA
  36. C242T polymorphism of NADPH oxidase p22phox gene reduces the risk of coronary artery disease in a random sample of Egyptian population
  37. Investigating the Cardio-Protective Abilities of Supplemental L-Arginine on Parameters of Endothelial Function in a Hypercholesterolemic Animal Model
  38. Interplay of vitamin D and nitric oxide in post-menopausal knee osteoarthritis
  39. Vitamin D Deficiency and Cardiovascular Disease: Potential Mechanisms and Novel Perspectives
  40. Effect of Polymorphisms in the NADSYN1/DHCR7 Locus (rs12785878 and rs1790349) on Plasma 25-Hydroxyvitamin D Levels and Coronary Artery Disease Incidence
  41. Insights on Vitamin D's Role in Cardiovascular Disease: Investigating the Association of 25-Hydroxyvitamin D with the Dimethylated Arginines
  42. Association of suboptimal 25-hydroxyvitamin D levels with knee osteoarthritis incidence in post-menopausal Egyptian women
  43. Changes in ADMA and TAFI levels after stenting in coronary artery disease patients
  44. Endothelial Nitric Oxide Synthase (G894T) Gene Polymorphism in a Random Sample of the Egyptian Population: Comparison with Myocardial Infarction Patients
  45. Association of DDAH2 gene polymorphism with cardiovascular disease in Egyptian patients
  46. Protective Effect of L-Arginine in Experimentally Induced Myocardial Ischemia: Comparison With Aspirin
  47. Assessment of serum levels of asymmetric dimethylarginine, symmetric dimethylarginine andl-arginine in coronary artery disease
  48. Anti-aging effects of l-arginine
  49. Lactoperoxidase catalyzes in vitro activation of acrylonitrile to cyanide
  50. Study of Some Inflammatory Factors in Type 2 Diabetic Patients with Nephropathy
  51. Oxidative Stress and Asymmetric Dimethylarginine Are Associated with Cardiovascular Complications in Hemodialysis Patients: Improvements by L-Arginine Intake
  52. hsCRP, sICAM-1 and TAFI in Hemodialysis Patients: Linking Inflammation and Hypofibrinolysis to Cardiovascular Events
  53. Biochemical study of the anti-diabetic action of the Egyptian plants Fenugreek and Balanites
  54. L -carnitine prevents the progression of atherosclerotic lesions in hypercholesterolaemic rabbits
  55. Regression of early events of atherosclerosis in hypercholesterolemic rabbits by prophylactic treatment with nitroderivative of acetyl salicylic acid
  56. Effect of Cadmium and Aluminum Intake on the Antioxidant Status and Lipid Peroxidation in Rat Tissues
  57. Protective effect of vitamin E, β-carotene and N-acetylcysteine from the brain oxidative stress induced in rats by lipopolysaccharide
  58. Protective role of nitric oxide in indomethacin-induced gastric ulceration by a mechanism independent of gastric acid secretion
  59. STUDY OF THE HYPOLIPIDEMIC PROPERTIES OF PECTIN, GARLIC AND GINSENG IN HYPERCHOLESTEROLEMIC RABBITS
  60. Effect of various stressors on the levels of lipid peroxide, antioxidants and Na+, K+-ATPase actrivity in rat brain
  61. Lipid peroxidation and lysosomal integrity in different inflammatory models in rats: The effects of indomethacin and naftazone
  62. Effect of pumpkin-seed oil on the level of free radical scavengers induced during adjuvant-arthritis in rats
  63. The distribution of non-specific carboxylesterases and glutathione S-transferases in different rat liver cells